Posted originally on May 18, 2025 by Martin Armstrong 

Canada’s Ostrich Cull Scandal: Are Big Pharma and Globalist Interests Pulling the Strings?
When I first heard about the ostrich farm in Edgewood, British Columbia, facing a forced cull of 400 ostriches, something immediately felt off. Sure, authorities claim they’re responding to an avian flu outbreak—but the deeper I dig into this, the more it smells of something else entirely. Let’s get right into it, because this isn’t just about bird flu—this is about science, censorship, profits, and powerful global interests that seem determined to control the narrative and crush alternatives.

The Edgewood Ostrich Outrage: How We Got Here

Picture a remote, idyllic farm in British Columbia’s Kootenay region, home to about 400 ostriches on 65 acres. On December 31, 2024, two ostriches tragically die of H5N1 avian flu, reportedly brought by wild migratory birds. This leads to a swift quarantine by the Canadian Food Inspection Agency (CFIA)—but that’s just the beginning.

Incredibly, after the initial outbreak, only about 40 birds (roughly 10% of the flock, mainly younger ostriches) succumb to the virus. Within just days, something remarkable occurs: the flock stabilizes, and the remaining 90% of the birds are thriving. Farm owner Karen Espersen observes that these ostriches seem to develop immunity, something clearly special and scientifically fascinating.

Yet despite the farm’s desperate pleas for additional testing and careful scientific study, the CFIA orders all ostriches culled—every last healthy bird—to supposedly “prevent the spread.” The family fights back, but on May 13, 2025, the Canadian Federal Court sides with the CFIA, leaving no room for appeal. The ostriches, despite clear evidence of recovery and possible immunity, are condemned to death.

Why the rush to destroy animals that might be holding keys to groundbreaking treatments? Why no interest in studying them further?

Ostrich Eggs and Antibodies: A Game-Changing Threat to Big Pharma?
Here’s where it gets interesting. Ostriches aren’t just giant flightless birds—they are potent biological factories. Their eggs contain powerful antibodies that have already demonstrated incredible therapeutic potential. Each ostrich egg can yield as many antibodies as 100 chicken eggs or 800 rabbits. That’s not just impressive, it’s potentially disruptive to the pharmaceutical industry.

Dr. Yasuhiro Tsukamoto (nicknamed “Dr. Ostrich”), a prominent Japanese veterinary immunologist, has been leading pioneering research using ostrich antibodies. His work, in collaboration with the Edgewood farm, produced breakthrough products during the COVID-19 crisis, including masks and nasal sprays coated with ostrich antibodies that neutralize viruses effectively. Hospitals in Japan even ran successful clinical trials using ostrich antibody nasal sprays for virus prevention.

Now, apply this logic to avian flu—a virus global health authorities (including the WHO and World Economic Forum) are increasingly hyping as “the next COVID,” predicting global outbreaks and calling for new mass vaccination programs. If ostrich antibodies could provide effective natural immunity or treatment against bird flu, that could render new vaccines—particularly expensive, patented mRNA vaccines—unnecessary or less profitable.

It’s not a stretch to see why pharmaceutical giants might perceive ostrich antibodies as a direct threat: cheap, natural, effective, and impossible to monopolize like lab-engineered vaccines.

The Pharma Connection: Is Big Money Silencing Alternative Solutions?
As I researched deeper, disturbing questions arose. According to the ostrich farm owners, CFIA officials bizarrely grilled them about their proprietary antibody research during quarantine meetings—unusual questioning, to say the least, for an agency supposedly just concerned with containment. Why was a regulatory agency suddenly so interested in proprietary intellectual property?

From my perspective, this screams of corporate influence—exactly the type of “public-private partnership” favored by groups like the World Economic Forum, where regulatory agencies and pharmaceutical interests often blend seamlessly.

Indeed, ostrich antibodies represent precisely the kind of “inconvenient science” that Big Pharma—and powerful globalist institutions like the WHO and WEF—would rather not let flourish. After all, if a farmer in British Columbia could produce inexpensive antibody-based solutions to avian flu, COVID, or other pandemics, why would governments invest billions in patented mRNA technologies championed by the pharmaceutical establishment?

This dynamic mirrors precisely what we’ve seen throughout COVID: affordable, natural solutions systematically sidelined in favor of profitable, patent-protected vaccines and treatments. And let’s be honest—the upcoming bird flu “crisis” narrative feels suspiciously similar to the lead-up to the COVID pandemic: a hyped-up global threat, new vaccines in the pipeline, and massive profits at stake.

A Pattern of Suppression: “Trust the Science”…or Else?
Critically, the CFIA’s rigid refusal to even consider alternative solutions or studies of these potentially immune birds exposes a deeper pattern of institutional inflexibility—or intentional suppression. Despite the farm’s strict quarantine, remote location, and documented immunity of surviving birds, authorities refused any meaningful investigation or testing, stubbornly adhering to blanket policies that conveniently shut down independent science.

Even respected veterinarians like Dr. Scott Weese from the University of Guelph have pointed out the irrationality: “We’re not eradicating H5N1 by culling these ostriches,” he said plainly. Premier David Eby of British Columbia even questioned why there’s no “case-by-case” flexibility, expressing frustration at the CFIA’s blanket policy.

Yet the authorities wouldn’t budge an inch. The message is clear: “Trust our science, no questions allowed.”

Public Outrage and the Fight for Truth
The outrage from the farm, community, and global observers has been intense. Activists and animal advocates descended on Edgewood, physically trying to block the cull and livestreaming desperate pleas for help. Even Robert F. Kennedy Jr., known for challenging the COVID vaccine narrative, weighed in, calling the planned ostrich cull “horrifying.”

The farm’s supporters—and I count myself among them—see this cull as part of a larger pattern: global health authorities and big-money pharmaceutical interests systematically suppressing any inexpensive, natural, and non-patentable solutions. The ostrich antibodies represent exactly the kind of disruptive innovation that global elites, aligned with pharma profits and pandemic narratives, want silenced.

Coincidence or Conspiracy? The Bigger Picture Emerges
Is it mere coincidence that, just as ostrich antibodies were demonstrating real promise as inexpensive, natural antiviral solutions, Canadian authorities swiftly moved to destroy the birds producing them?

While no court case or official inquiry directly proves Big Pharma influence on CFIA’s decision, context matters greatly. The aggressive stance of global health organizations promoting the avian flu as “the next big threat,” coupled with heavy investment in mRNA vaccine technology, makes ostrich-derived natural immunity research deeply inconvenient. Powerful financial interests would clearly benefit from removing such competition.

Even Canadian MLAs and animal-rights advocates are questioning whether something darker lies behind this incident. It may not be outright conspiracy—though that can’t be ruled out—but rather the structural, systemic alignment between big-money pharmaceutical interests, compliant government agencies, and international globalist institutions promoting centralized pandemic responses.

Looking Ahead: Fighting for Transparency and Real Science
This ostrich farm incident isn’t just another animal culling. It’s a symptom of a broader struggle—science versus profit, freedom versus control, transparency versus censorship.

We have an opportunity to push back, demanding full transparency from government and health authorities. We must insist on fair, unbiased scientific inquiry into promising alternatives, no matter how disruptive they may be to established financial or political interests.

Imagine if Canadian authorities had paused to thoroughly investigate these ostriches’ apparent immunity. Imagine a world where inexpensive, effective ostrich antibodies became a mainstream, natural alternative to costly pharmaceutical vaccines. Unfortunately, this scenario directly threatens too many entrenched interests to be allowed to develop without resistance.

We can’t allow powerful actors to squash independent innovation under the guise of “public health.” The Edgewood ostrich cull should be a wake-up call: it’s about far more than birds—it’s about the future of medical freedom, scientific transparency, and resisting the weaponization of fear-based pandemic narratives for profit and control.

Let’s keep our eyes wide open—and keep digging.